| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00098 | 1 |